Intrinsic Value of S&P & Nasdaq Contact Us

Aravive, Inc. ARAV NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
39/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$0.25
+523.4%

Aravive, Inc. (ARAV) — Analyst outlook / Analyst consensus target is. Based on 18 analyst ratings, the consensus is bullish — 8 Buy, 9 Hold, 1 Sell.

The consensus price target is $0.25, representing an upside of 523.4% from the current price $0.04.

ARAV Stock — 12-Month Price Forecast

$0.25
▲ +523.44% Upside
Average Price Target
Based on 18 Wall Street analysts offering 12-month price targets for Aravive, Inc., the price target is $0.25.
The average price target represents a +523.44% change from the last price of $0.04.

ARAV Analyst Ratings

Hold
18
Ratings
8 Buy
9 Hold
1 Sell
Based on 18 analysts giving stock ratings to Aravive, Inc. in the past 3 months
Rating breakdown
Buy
8 44%
Hold
9 50%
Sell
1 6%
44%
Buy
8 analysts
50%
Hold
9 analysts
6%
Sell
1 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message